LLY vs ABBV
LLY and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | LLYELI LILLY AND COMPANY | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $1.07T | $463.96B |
| P/E (TTM) | 38.2 | 74.2 |
| P/B | 31.63 | — |
| P/S | 16.4x | 7.6x |
| Dividend yield | 0.50% | 2.51% |
| Revenue | $79.67B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | 44.7% | 8.6% |
| Net income | $26.71B(TTM) | $6.31B(TTM) |
| Earnings growth (YoY) | 94.9% | -1.2% |
| EPS, diluted | $29.79(TTM) | $3.54(TTM) |
| EBIT margin | 40.2% | 24.6% |
| ROE | 60.9% | — |
| ROIC | 26.3% | 18.6% |
| 1y total return | +49.7% | +24.5% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: LLY frente a ABBV
| Métrica | LLY | ABBV |
|---|---|---|
| Valor final | $175.4K | $64.4K |
| Retorno total | +1654.3% | +543.9% |
| CAGR | +31.9% | +19.7% |
| Volatilidad | 30.1% | 25.9% |
| Sharpe | 0.93 | 0.67 |
| Sortino | 1.45 | 0.93 |
| Caída máxima | -34.5% | -45.1% |
Basado en 2600 días de negociación comunes, 2016-05-13 → 2026-09-16 · tasa libre de riesgo 4.14% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)